Pancreatic Polypeptide

DB12822InvestigationalProtein Based Therapies

Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.

Mechanism: Pharmacologically active on Neuropeptide Y receptor type 4 and Neuropeptide Y receptor type 4-2
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pancreatic Polypeptide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.